• Madrigal Pharmaceuticals average return on equity for 2023 was -292.14, a 2.72% decline from 2022.
• Madrigal Pharmaceuticals average return on equity for 2022 was -300.3, a 211.71% decline from 2021.
• Madrigal Pharmaceuticals average return on equity for 2021 was -96.34, a 77.49% increase from 2020.

Roe - return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.